Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Vues
• 07/09/23
0
0
Intégrer
administrator
Les abonnés
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires